Lyell Immunopharma Inc Strategic Asset Allocation Index
Lyell Immunopharma Inc strategic asset allocation index. Lyell Immunopharma Inc (LYEL) has a Strategic Asset Allocation Index of 18.3% as of June 2026. Strategic assets (PP&E of $- plus long-term investments of $42.90 Million) total $42.90 Million, measured against net assets of $233.81 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Lyell Immunopharma Inc balance sheet independence to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Lyell Immunopharma Inc (2019–2025)
Strategic asset allocation index of Lyell Immunopharma Inc from 2019 to 2025. This chart shows how Lyell Immunopharma Inc's Strategic Asset Allocation Index has evolved across 7 annual periods from 2019 to 2025. As of June 2026, the index stands at 18.3%, representing strategic assets of $42.90 Million against net assets of $233.81 Million USD. Check LYEL goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Lyell Immunopharma Inc Strategic Asset Allocation Index by Year (2019–2025)
Lyell Immunopharma Inc strategic asset allocation index by year from 2019 to 2025. The table below presents the year-by-year Strategic Asset Allocation Index for Lyell Immunopharma Inc from 2019 to 2025, covering 7 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see LYEL market cap overview.
| Year | SAAI | Strategic Assets (USD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 7.7% | $19.00 Million | $- | $19.00 Million | $248.20 Million | ▼ -0.7 pp |
| 2024 | 8.4% | $32.01 Million | $- | $32.01 Million | $382.82 Million | ▲ +1.0 pp |
| 2023 | 7.4% | $48.51 Million | $- | $48.51 Million | $654.95 Million | ▼ -26.4 pp |
| 2022 | 33.8% | $281.31 Million | $166.26 Million | $115.04 Million | $833.25 Million | ▼ -14.7 pp |
| 2021 | 48.5% | $450.63 Million | $120.10 Million | $330.53 Million | $929.79 Million | ▲ +8.4 pp |
| 2020 | 40.0% | $287.50 Million | $124.06 Million | $163.44 Million | $718.44 Million | ▲ +12.4 pp |
| 2019 | 27.6% | $112.69 Million | $43.70 Million | $68.98 Million | $408.06 Million | — |